Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience

BACKGROUND: Effective treatment options for advanced pancreatic cancer are finite. NAPOLI-1, a phase III randomized trial, demonstrated the efficacy of nanoliposomal irinotecan with fluorouracil/leucovorin (nal-IRI + 5-FU/LV) for the treatment of advanced pancreatic cancer following progression on g...

Descripción completa

Detalles Bibliográficos
Autores principales: Glassman, Danielle C., Palmaira, Randze L., Covington, Christina M., Desai, Avni M., Ku, Geoffrey Y., Li, Jia, Harding, James J., Varghese, Anna M., O’Reilly, Eileen M., Yu, Kenneth H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020418/
https://www.ncbi.nlm.nih.gov/pubmed/29945562
http://dx.doi.org/10.1186/s12885-018-4605-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020418/
https://www.ncbi.nlm.nih.gov/pubmed/29945562
http://dx.doi.org/10.1186/s12885-018-4605-1

Ejemplares similares